NUS Healthy Longevity Executive Masterclass

Programme Highlights

Longevity is emerging as a major market shift, and separating meaningful opportunities from hype is becoming increasingly difficult. Advances in biological age measurement, biomarkers, wearables, multi-omics, AI and health technology are reshaping healthcare, insurance, finance, consumer markets and everyday life. For organisations, the question is no longer simply what the science can do, but where healthy longevity creates value, which opportunities are ready to act on, and which require more evidence.

The NUS Healthy Longevity Executive Masterclass is designed for senior leaders who make those decisions.

Over three intensive days, participants will build the scientific literacy needed to critically evaluate longevity claims, examine the emerging longevity economy, and apply evidence to organisational strategy, investment, workforce planning and product development.

Participants will also experience elements of precision health firsthand through clinical assessments and continuous glucose monitoring (CGM), using their own data as a practical lens through which to examine the opportunities and limitations of emerging health technologies.

Bring one strategic question that matters to your organisation. Leave with a position on it.

Throughout the programme, participants will frame the opportunity and risk, pressure-test their assumptions against scientific evidence and expert perspectives, and determine an appropriate position: advance, pilot, revise, hold or decline.

No prior scientific background is required. The programme is taught by faculty with direct research expertise in healthy longevity and related fields.

Interested in joining a future intake of the NUS Healthy Longevity Executive Masterclass?

While registration for the Masterclass is not currently open, we invite you to register your interest to receive updates on future Masterclass dates and registration details as they become available.

For further enquiries, please contact us at medicine.cet@nus.edu.sg.

Benefits of Attending

• Understand the Longevity Economy: Examine how advances in healthy longevity, emerging technologies and demographic change are creating new opportunities and risks across industries.
• Separate Signal from Hype: Build the scientific literacy to critically evaluate claims around biological age, biomarkers, wearables, interventions and emerging health technologies. 
• Pressure-Test a Real Strategic Question: Bring a live question from your organisation and examine it against market developments, scientific evidence and expert perspectives throughout the programme.
• Experience Precision Health Firsthand: Use clinical assessments and your own health and CGM data to explore the opportunities and limitations of the data-driven health models increasingly being considered by health systems, employers and consumer markets.
• Translate Evidence into Organisational Decision: Apply what you learn to strategy, investment, workforce planning, product development and other decisions relevant to your organisation.
• Access NUS Medicine’s Research Frontier: Engage directly with faculty working in healthy longevity and related fields and interrogate the evidence at its source.
• Join a Curated Executive Peer Network: Learn alongside senior leaders responsible for strategy, investment, innovation and organisational decision-making across sectors.

Who Should Attend?

The Masterclass is designed for senior leaders who set strategy, allocate capital and shape how their organisations respond to longer, healthier lives.

It is particularly relevant for:

• Enterprise Leaders: CEOs, presidents, board directors, business owners, heads of strategy and business-unit leaders.
• Capital & Investment Leaders: Investors, family offices, private equity leaders and corporate venture teams.
• Growth & New Business Leaders: Founders, innovators and senior executives exploring opportunities in health and adjacent markets.
• Senior Decision-Makers Across Sectors: Leaders in healthcare and life sciences, financial services and insurance, consumer industries, technology, real estate, government and other sectors where longevity is becoming strategically relevant.

No prior knowledge of ageing biology, genomics or biological age is required.

Course Agenda

• ( Day 1 ) Understanding the Longevity Landscape 

  Build the foundation needed to navigate the longevity economy. Examine the biology of ageing, biological age measurement, biomarkers and emerging technologies, including a hands-on exploration of real -time CGM data.

  Consider where the market stands today, where meaningful opportunities are emerging and what developments may matter to your organisation.

  Begin framing the strategic question you will pressure-test throughout the programme.

• ( Day 2 ) From Evidence to Opportunity

  Examine what the evidence says about interventions intended to support healthier longevity, including lifestyle, exercise and emerging therapeutics.

  Through performance testing and clinical assessments conducted by the NUS Academy’s Clinical Trial Centre, experience elements of the precision-health landscape firsthand and consider how these approaches could translate into products, services, workforce strategies and investment opportunities.

  Use the evidence and expert perspectives to challenge assumptions surrounding your strategic question.

• ( Day 3 ) From Evidence to Strategy

  Turn insight into a position.

  Through industry-focused roundtables and multidisciplinary discussion, examine where longevity could create value for your organisation, and where the evidence may not yet support action.

  Conclude by determining your position on the strategic question you brought to the programme: advance, pilot, revise, hold or decline.

  Leave with a clearer view of where longevity fits your strategy and what should happen next.

Minimum Entry Requirement

• Experience: Minimum 10 years of relevant professional experience. Participants should typically hold senior responsibility for strategy, investment, innovation, organisational leadership or related decision-making.
• Education: Degree-level qualification or equivalent professional experience.
• Language: Proficiency in English (language of instruction).
• Scientific Background: No prior scientific background is required. The programme provides the scientific foundation necessary to evaluate evidence and participate fully in discussions.

Awards and Certification

Participants who fulfil a minimum of 75% attendance will receive the:

NUS Certificate of Participation — Healthy Longevity Executive Masterclass

Issued by the NUS Yong Loo Lin School of Medicine, Academy of Healthy Longevity.

Course Fee

SGD $9,900 (subject to prevailing GST )

• 10% Discount for NUS Medicine Alumni
• 10% Group enrolment of at least 3 participants.